Document is current
Any future updates will be listed below
-
Authors
Martinez Heinemann, Daniel https://orcid.org/0009-0003-5169-2393
Bodden, Jannis
Endroes, Lukas
Teresa, Felianty
Nickel, Manuel
Lange, Sebastian
Mergen, Markus
Spitzl, Daniel
Schmid, Roland
Martignoni, Marc
Kirschke, Jan
Eiber, Matthias
Braren, Rickmer
Steinhelfer, Lisa
-
Funding
Funding for this research was provided by:
Technische Universität München
- License Information
-
More Information
Article History
Received: 28 April 2026
Accepted: 26 June 2026
First Online: 4 July 2026
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Technical University of Munich, TUM Klinikum Rechts der Isar (reference 87/18S).
: Written informed consent for clinically indicated CT imaging, interventional procedures, and laboratory assessments was obtained as part of routine care. The requirement for additional study-specific informed consent was waived by the local ethics committee due to the retrospective study design.
: Prof. Eiber reports consultancy and/or research support from Blue Earth Diagnostics, Novartis/AAA, Telix, Bayer, RayzeBio, Point Biopharma, Eckert & Ziegler, Janssen Pharmaceuticals, Parexel, and Bioclinica, as well as a patent application for rhPSMA. Dr. Lange reports honoraria/speaker fees; service on advisory boards or travel support: Taiho, AstraZeneca, Jazz, Daiichi Sankyo, Janssen-Cilag, MSD.
